- Louis Muglia, MD, PhD, Division Director
Dr. Muglia is an Alumni Endowed Professor of Pediatrics within the Division of Pediatric Endocrinology and Diabetes at Washington University School of Medicine; Professor of Molecular Biology and Pharmacology, Director, Center for Preterm Birth Research; Unit Leader Developmental Biology and Genetics. Dr. Muglia received his MD and PhD degrees from the University of Chicago Pritzker School of Medicine as a member of the Medical Scientist Training Program, and went on to complete his pediatric residency and pediatric endocrinology fellowship at Children’s Hospital, Boston. Dr. Muglia joined the Division of Pediatric Endocrinology and Diabetes at Washington University in 1996, and is board certified in Pediatrics and Pediatric Endocrinology. He is a member of both the Endocrine Society and the Lawson Wilkins Pediatric Endocrine Society. His clinical interests include a wide range of endocrine disorders, with special emphasis on pituitary and adrenal diseases.
Dr. Muglia received the prestigious Young Investigator's Award from the Society for Pediatric Research in 1999 and was elected to membership in the American Society for Clinical Investigation in 2003.
The research efforts of Dr. Muglia’s laboratory center on defining the role of neuropeptides produced by the hypothalamus in perinatal adaptation, reproduction, and behavior. To this end, they have developed murine transgenic and gene inactivation models to assess the in vivo functions of corticotropin-releasing hormone (CRH), oxytocin (OT), and adenylyl cyclase type VIII (AC8).
- Ana Maria Arbelaez, MD
Dr. Arbelaez joined the St. Louis Children’s Hospital staff in 2005 and serves as an Instructor in Pediatrics in the Division of Endocrinology and Diabetes at Washington University School of Medicine. She completed her pediatric residency training at St. Louis Children’s Hospital followed by a fellowship in pediatric endocrinology and diabetes. Dr. Arbelaez maintains an active program in general endocrinology and diabetes with specific research interest in hypoglycemia associated with the treatment of diabetes and cystic fibrosis-related diabetes.
- Rebecca P. Green, MD, PhD
Dr. Green joined the Division of Pediatric Endocrinology and Diabetes at Washington University School of Medicine in 2000 and serves as an Assistant Professor of Pediatrics. Dr. Green received her MD and PhD degrees from Washington University School of Medicine and completed her pediatric residency and fellowship training at St. Louis Children’s Hospital. She is board certified in Pediatrics and Pediatric Endocrinology. Dr. Green is a member of numerous organizations, including The American Academy of Pediatrics, The American Diabetes Association, The Endocrine Society, The Lawson Wilkins Pediatric Endocrine Society, The American Society of Bone and Mineral Research and the International Bone and Mineral Research Society. Her clinical interests extend to all areas of pediatric endocrinology and metabolism, with a particular interest in metabolic bone disease.
- Abby Hollander, MD, Clinical Director
Dr. Hollander joined the Division of Pediatric Endocrinology and Diabetes at Washington University School of Medicine in 1992 and serves as an Associate Professor of Pediatrics and Director of the Division of Pediatric Ambulatory Medicine. Her pediatric residency was completed at the Children’s Memorial Hospital in Chicago, Illinois. She is a graduate of the Fellowship Program in Pediatric Endocrinology and Diabetes at St. Louis Children’s Hospital and Washington University School of Medicine and is board certified in pediatrics and pediatric endocrinology. She is currently on the Clinician Educator Track. Her clinical interests cover all aspects of pediatric endocrinology, including growth disorders, thyroid disorders, pubertal disorders, adrenal disease and diabetes.
Dr. Hollander is a member of the American Academy of Pediatrics, the American Diabetes Association, the Endocrine Society and the Lawson Wilkins Pediatric Endocrine Society. Dr. Hollander has been involved in several clinical research projects. Over the past five years, she has presented information at national meetings regarding the molecular variants of growth hormones, the use of insulin pumps in children, and complicated presentations of type 2 diabetes in adolescents. She has been an investigator in exciting multi-center studies that are looking at new therapies in diabetes mellitus, growth hormone deficiency and hypothalamic obesity. She is working with Neil White, MD, to define the risks and benefits of insulin pump therapy in children with diabetes.
Dr. Hollander is very involved with the local chapter of the American Diabetes Association, and has been a member of the Camp Committee, Youth Group and the Board of Directors. She has been a Diabetes Camp Physician since 1990 and became Medical Director of the camp in 2001.
- Paul Hruz, MD, PhD
Dr. Hruz is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology and Diabetes at Washington University School of Medicine. As a member of the Medical Scientist Training Program at the Medical College of Wisconsin, he received his PhD Degree in Biochemistry in 1993 and MD Degree in 1994. Dr. Hruz then received residency training in pediatrics at the University of Washington in Seattle. He was appointed a fellow in pediatric endocrinology and diabetes at Washington University School of Medicine in 1997 and joined the faculty in 2000.
Dr. Hruz is board certified in pediatrics and pediatric endocrinology and metabolism. Dr. Hruz has clinical interest in a wide range of endocrine disorders, with a special interest in diabetes mellitus. He is a member of the American Academy of Pediatrics, the American Diabetes Association, the American Medical Association, the American Association for the Advancement of Science, the Endocrine Society and the Lawson Wilkins Pediatric Endocrine Society.
Dr. Hruz’s research interests include intermediary carbohydrate metabolism, glucose transporter structure and function, mechanism of insulin action, and the molecular mechanisms leading to congenital and acquired lipodystrophies.
- Bess A. Marshall, MD
Dr. Marshall joined the Division of Pediatric Endocrinology and Diabetes at Washington University School of Medicine in 1993 and serves as an Associate Professor of Pediatrics. She received her MD Degree from the Vanderbilt University School of Medicine in 1986. Dr. Marshall served an internship and residency in Pediatrics at the University of Texas, Southwestern Health Sciences Center, Children's Medical Center of Dallas, and Parkland Memorial Hospital in Dallas. In 1990, she was appointed a fellow in pediatric endocrinology and diabetes at Washington University School of Medicine.
Dr. Marshall’s clinical interests include diabetes and all aspects of endocrinology and metabolism. She is a fellow of the American Academy of Pediatrics and a member of the Lawson Wilkins Pediatric Endocrine Society, the European Association for the Study of Diabetes, the International Diabetes Federation, the American Diabetes Association, the Endocrine Society, and is a charter member of the American Association of Clinical Endocrinologists. She is board certified in pediatrics and pediatric endocrinology.
Dr. Marshall’s research interests include intermediary carbohydrate metabolism, glucose transporter structure and function mechanisms of insulin resistance, and metabolic control of insulin secretion. She has been funded by a National Institutes of Health Clinician - Investigator Development award, the Hardison Family Foundation and the National Institutes of Health NIDDK. She has been a scholar of the Child Health Research Center of Excellence in Developmental Biology at Washington University.
- Lori Wagner, MD
- Neil White, MD, CDE
Dr. White is a Professor of Pediatrics in the Division of Pediatric Endocrinology and Diabetes at Washington University School of Medicine. Dr. White received his MD Degree from Albert Einstein College of Medicine. He completed his post-graduate pediatric and pediatric endocrinology training at St. Louis Children’s Hospital and then served as an Assistant Professor of Pediatrics in the Division of Endocrinology and Metabolism from 1980-1987. From 1987 to 1991, he served as Associate Professor of Pediatrics and Communicable Diseases at the University of Michigan School of Medicine, and as Associate Director of the Clinical Implementation Core of the Michigan Diabetes Research and Training Center. Dr. White returned to Washington University in 1991. He is also Co-Unit Leader of the Pediatric Patient-Oriented Research Unit (PORU) of the Department of Pediatrics and Associate Program Director (with responsibilities for the pediatric unit) of the Washington University General Clinical Research Center. He is board certified in pediatrics and pediatric endocrinology and is a Certified Diabetes Educator (CDE).
Dr. White is a member of multiple professional societies including the Professional Section of the American Diabetes Association, the American Federation for Medical Research, the Lawson Wilkins Pediatric Endocrine Society, the Society for Pediatric Research, the American Pediatric Society, the International Society for Pediatric and Adolescent Diabetes, the Endocrine Society, the International Diabetes Federation, and the Juvenile Diabetes Research Foundation.
He has had a longstanding involvement with the American Diabetes Association at the local, state, regional, and national level and has served on many boards and committees. These have included his involvement as a member of the Research Grant Review Panel, the Scientific Sessions Planning Committee, and the Camp Task Force of the American Diabetes Association (ADA) and as Program Chairman and subsequently Chairman of the Council on Diabetes in Youth of the ADA. He is a past-president of the St. Louis Chapter of the American Diabetes Association. Dr. White has also had a 20- year involvement in the organization and operation of camps for diabetic children and was the recipient of the award for Outstanding Contribution to Diabetes and Camping of the American Diabetes Association in 1998.
Over the last 25 years, Dr. White's research interests have included active participation as a co-investigator and subsequently co-principal investigator of the Diabetes Control and Complications Trial (DCCT) both at Washington University and the University of Michigan. He is currently the principal investigator at Washington University for the DCCT/EDIC study. He has had an ongoing interest in the methods of intensive therapy in type 1 and the risk of hypoglycemia as part of this therapy. He also oversees the Diabetes Prevention Program (DPP) and the DPP Outcomes Study (DPPOS), multiple trials of psychosocial interventions in diabetic teenagers, and the local centers of the Type 1 Diabetes TrialNet and TRIGR studies (related to prevention of type 1 diabetes) and the STOPP-T2D/TODAY study (related to treatment and prevention of type 2 diabetes in youth).